<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AJPS</journal-id><journal-title-group><journal-title>American Journal of Plant Sciences</journal-title></journal-title-group><issn pub-type="epub">2158-2742</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ajps.2022.135043</article-id><article-id pub-id-type="publisher-id">AJPS-117456</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Salivary Active MMP-2 of Breast Cancer Patients Is Inhibited by Guava Leaves PBS Extract
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ramanuj</surname><given-names>Mukherjee</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Syandan</surname><given-names>Sinha Ray</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Subhajit</surname><given-names>Mondal</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Amitava</surname><given-names>Chatterjee</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Ramakrishna Mission Vivekananda Educational &amp;amp; Research Institute, Kolkata, India</addr-line></aff><aff id="aff1"><addr-line>R G Kar Medical College, Kolkata, India</addr-line></aff><pub-date pub-type="epub"><day>16</day><month>05</month><year>2022</year></pub-date><volume>13</volume><issue>05</issue><fpage>650</fpage><lpage>658</lpage><history><date date-type="received"><day>14,</day>	<month>March</month>	<year>2022</year></date><date date-type="rev-recd"><day>27,</day>	<month>May</month>	<year>2022</year>	</date><date date-type="accepted"><day>30,</day>	<month>May</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Matrixmetalloproteinase-2 (MMP-2), also called gelatinase-A, is a 72 Kd protein present in chromosome 16 in human. It is a zinc binding protein, responsible for the degradation of Extra Cellular Matrix (ECM) in normal physiological as well as disease processes like arthritis and cancer. It has a specific role in the cancer development and angiogenesis. MMP-2 contributes to cell migration. MMPs are the key to normal development as well as in the pathology of cancer and other inflammatory diseases. The inhibitors of MMP-2 activity are very important in maintaining the normal activity of MMP-2 and have an important role in the management of cancer. Regulation of MMP-2 activity is done by inhibitors like, TIMPs. In this report, we are discussing about a possible inhibitor(s) present in the PBS extract of guava leaves, inhibiting the active MMP-2 present in the saliva of breast cancer patients.
 
</p></abstract><kwd-group><kwd>MMP-2</kwd><kwd> Inhibitor</kwd><kwd> Saliva</kwd><kwd> Breast Cancer</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Matrixmetalloproteinases, family of enzymes, are extracellular matrix remodeling proteases whose activity has been implicated in a number of important normal and pathological processes [<xref ref-type="bibr" rid="scirp.117456-ref1">1</xref>]. Growth of tumor progression and metastasis as well as angiogenesis is associated with these events [<xref ref-type="bibr" rid="scirp.117456-ref2">2</xref>]. MMP-2, also called gelatinase-A, is a 72 Kd protein present in chromosome 16 in humans. MMP-2 contributes to cancer cell migration [<xref ref-type="bibr" rid="scirp.117456-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.117456-ref4">4</xref>], Cartoons 1(a) &amp; Cartoons 1(b). MMPs are the key to normal development as well as the pathology of inflammatory diseases and cancer [<xref ref-type="bibr" rid="scirp.117456-ref2">2</xref>]. The inhibitors of MMP-2 activity [like</p><disp-formula id="scirp.117456-formula53"><graphic  xlink:href="//html.scirp.org/file/8-2605268x2.png?20220530092237018"  xlink:type="simple"/></disp-formula><p>Cartoons 1. (a) Cell migration; (b) Mechanism of MMP-2 activation.</p><p>TIMP-2] are very important in maintaining the normal activity of MMP-2 and have an important role in the management of cancer [<xref ref-type="bibr" rid="scirp.117456-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.117456-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.117456-ref7">7</xref>]. MMP-2 has attracted attention by its roles in tumor invasion and metastasis. It was reported [<xref ref-type="bibr" rid="scirp.117456-ref8">8</xref>] that breast cancer patients’ saliva contains active MMP-2. Taking breast cancer patients’ (female) saliva as the source of active MMP-2 it was found that guava leaves extract can reduce the activity of MMP-2 in appreciable level [<xref ref-type="bibr" rid="scirp.117456-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.117456-ref10">10</xref>]. The chemical nature of the MMP-2 inhibitor in guava leaves PBS extract is yet to be established. The anticancer effect of guava leaves extracts was studied in details [<xref ref-type="bibr" rid="scirp.117456-ref9">9</xref>]. The ethanol extract of Psidiumguajava leaves extract has potential in the treatment of colorectal cancer through the angiogenesis inhibition [<xref ref-type="bibr" rid="scirp.117456-ref9">9</xref>]. ProMMP-2 is not readily activated by general proteinases. The main activation of MMP-2 takes place on the cell surface, mediated by MT1-MMP [<xref ref-type="bibr" rid="scirp.117456-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.117456-ref12">12</xref>]. This MT1-MMP-TIMP-2-proMMP-2 complex is then presented to an adjacent free MT1-MMP for activation. Clustering of MT1-MMP on cell surface through interactions of the hemopexin domain facilitates the activation process [<xref ref-type="bibr" rid="scirp.117456-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.117456-ref12">12</xref>].</p><p>Previous studies have demonstrated that MMP-2 and MMP-9 are important prognostic factors for various cancers [<xref ref-type="bibr" rid="scirp.117456-ref13">13</xref>]. The prognostic value of MMP-2/9 in Breast Cancer has been investigated [<xref ref-type="bibr" rid="scirp.117456-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.117456-ref13">13</xref>].</p><p>In this study, we are interested to see whether the PBS extract of guava leaves has any specific effects on the activity of salivary active MMP-2 of breast cancer patients.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Materials</title><p>The materials for SDS-PAGE was purchased from Sigma, USA. The monoclonal antibodies of MMP-2 and TIMP-2 were purchased from Santa Cruz, USA and the Pronase-K was purchased from G-Biosciences, USA.</p></sec><sec id="s2_2"><title>2.2. Methods</title><sec id="s2_2_1"><title>2.2.1. Substrate Gel Electrophoresis (Zymography)</title><p>Equal amount (100 &#181;g) of proteins from saliva (determined by Lowry’s method) run in 8% SDS-PAGE impregnated with 0.1% Gelatin. The gel was run at 25 mA using Tris/Glycine/SDS buffer (pH 8.3). The gel was washed in 2.5% Triton-X for 15 mins and then incubated in buffer A (NaCl 0.2 M, CaCl<sub>2</sub> 4.5 mM, Tris 50 mM, pH 7.4) overnight at 37˚C. The gel was stained with Coomassie Brilliant Blue to develop the zymogram [<xref ref-type="bibr" rid="scirp.117456-ref8">8</xref>].</p></sec><sec id="s2_2_2"><title>2.2.2. ELISA (Enzyme-Linked Immunosorbent Assay)</title><p>To assay salivary MMP-2, TIMP-2, 50 &#181;g of salivary proteins were used to develop ELISA using their respective monoclonal antibodies followed by 2<sup>nd</sup> antibody coupled to horseradish peroxidase (HRP). OD was taken at 450 nM [<xref ref-type="bibr" rid="scirp.117456-ref8">8</xref>].</p></sec><sec id="s2_2_3"><title>2.2.3. Immunoblot Development</title><p>200 &#181;g of salivary proteins were run on 8% SDS-PAGE. Proteins were transferred onto nitrocellulose membrane and immunoblots were developed using monoclonal antibody against MMP-2 (Santa Cruz, USA) followed by alkaline phosphatase coupled 2<sup>nd</sup> antibody. The color was developed using NBT/BCIP [<xref ref-type="bibr" rid="scirp.117456-ref8">8</xref>].</p></sec></sec></sec><sec id="s3"><title>3. Results</title><p><xref ref-type="fig" rid="fig1">Figure 1</xref> (lanes 1-4) shows that female breast cancer patients express appreciable amount of active MMP-2 in their saliva [<xref ref-type="bibr" rid="scirp.117456-ref8">8</xref>]. The lane 2 of <xref ref-type="fig" rid="fig1">Figure 1</xref> shows huge amount of MMP activity. The immunoblot which confirms that the MMPs secreted in breast cancer patients’ saliva are activated MMP-2 [<xref ref-type="bibr" rid="scirp.117456-ref8">8</xref>]. MMP-2 activity of breast cancer patients’ saliva increases stage wise has also been reported [<xref ref-type="bibr" rid="scirp.117456-ref8">8</xref>]. As controls, several samples of saliva of non breast cancer patients were taken (<xref ref-type="fig" rid="fig2">Figure 2</xref>(a), lanes 1-10). Several samples of non cancer patients (<xref ref-type="fig" rid="fig2">Figure 2</xref>(b), lanes 1-20) and normal female individuals (<xref ref-type="fig" rid="fig2">Figure 2</xref>(c), lanes 1-5) were also taken which does not show any activated (active form of) MMP-2. There are appreciable differences in the expression of active MMP-2 in female breast cancer patients and the non breast cancer patients and other controls. Cartoons 1(a) &amp; Cartoons 1(b) show that cell surface integrin receptors alpha5beta1 (α5β1) and alfaVbeta3 (αVβ3) and MT1-MMP have important roles to play in the cellular migration and activation of MMP-2. <xref ref-type="fig" rid="fig3">Figure 3</xref> shows that when guava leaves extract was added to the saliva of breast cancer patients [25 &#181;l of breast cancer patient’s saliva and 20 &#181;l of PBS extract of guava leaves incubated for 30 mins at 37˚C], the MMP-2 activity was appreciably reduced compared to controls, indicating presence of possible inhibitor(s) of active MMP-2 in the guava leaves PBS (x1, pH 7.4) extract [<xref ref-type="bibr" rid="scirp.117456-ref10">10</xref>]. <xref ref-type="fig" rid="fig4">Figure 4</xref> shows that when PBS extract of guava leaves was treated with Pronase-K (100 &#181;g/ml), the MMP-2 activity was coming back</p><p>probably indicating that the inhibitor(s) present in the PBS extract of guava leaves may be protein in nature. The guava leaves PBS extract (only) shows no gelatinase activity (band) (<xref ref-type="fig" rid="fig5">Figure 5</xref>). When reacted with the mouse/human TIMP-2 monoclonal antibody (Santa Cruz, USA) the ELISA of guava leaves PBS extract does not show any significant OD indicating that the inhibitor of active MMP-2 perhaps is not TIMP-2 (the known MMP-2 inhibitor) [<xref ref-type="bibr" rid="scirp.117456-ref10">10</xref>].</p><p>The inhibitor like molecule present in the PBS(x1) extract of Guava Leaves may be inhibitors of Zn 2+ at the active centre of MMP-2 but it may be worked out in the near future.</p><p>Interesting observation is that, active MMP-2 like molecule (probably) was observed in bamboo leaves PBS extract showing very positive results in ELISA and immunoblot with MMP-2 monoclonal antibody [<xref ref-type="bibr" rid="scirp.117456-ref14">14</xref>] which was also completely inhibited by guava leaves PBS extract [<xref ref-type="bibr" rid="scirp.117456-ref10">10</xref>].</p></sec><sec id="s4"><title>4. Discussion</title><p>The saliva of breast cancer patients contains activated MMP-2. The immunoblot clearly demonstrates that the expressed gelatinase-A/MMP-2 is reacting positively with MMP-2 monoclonal antibody. The inhibitor(s) of MMP-2 (to be identified) is very important for the research as well as for medical use. Different laboratories in the whole world are searching for new type of MMPs inhibitors from plant origin or synthetic inhibitors. In search of such MMP-2 modulator when guava leaves were extracted with PBS (pH 7.4) and reacted with breast cancer patients’ saliva the active MMP-2 was inhibited appreciably which may indicate presence of some inhibitor(s) of active MMP-2 of breast cancer patients saliva. To find out the nature of the inhibitor of MMP-2, the guava leaves extract was treated with Pronase-K (100 &#181;g/ml), the activity was coming back (<xref ref-type="fig" rid="fig4">Figure 4</xref>) perhaps indicating that the inhibitor may be protein in nature. The Guava leaves PBS extract does not show any gelatinase activity (band) (<xref ref-type="fig" rid="fig5">Figure 5</xref>). ELISA was done of the guava leaves PBS extract with human/mouse TIMP-2 monoclonal antibody, but it was found that guava leaves PBS extract probably does not contain any TIMP-2 like molecule [<xref ref-type="bibr" rid="scirp.117456-ref10">10</xref>]. The immunoprecipitate also confirmed that breast cancer patients’ saliva has activated MMP-2 products [<xref ref-type="bibr" rid="scirp.117456-ref8">8</xref>].</p><p>Interestingly, the PBS extract of bamboo leaves express very strong activated MMP-2 like molecule and its product (<xref ref-type="fig" rid="fig6">Figure 6</xref>) which gives positive results in ELISA and immunoblot using human/mouse monoclonal MMP-2 antibody [<xref ref-type="bibr" rid="scirp.117456-ref14">14</xref>]. This plant derived probably gelatinase-A/MMP-2 activity is also completely inhibited by the PBS extract of guava leaves [<xref ref-type="bibr" rid="scirp.117456-ref10">10</xref>].</p></sec><sec id="s5"><title>5. Conclusion</title><p>Guava leaves PBS extract (1x) may contain one or more inhibitors of activated MMP-2. This inhibits mammalian activated MMP-2 as well as plant activated MMP-2 like molecule. The activated MMP-2 inhibitor(s), if identified, will be very important in the management of breast cancer in future.</p></sec><sec id="s6"><title>Acknowledgements</title><p>We are grateful to our university’s vice chancellor and pro chancellor for allowing us to use the laboratory and chemicals.</p></sec><sec id="s7"><title>Contribution of Authors</title><p>Amitava Chatterjee is the Principal Investigator, Syandan Sinha Ray and Subhajit Mondal did the experiments, and Ramanuj Mukherjee is the Professor in Surgical Oncology, R. G. Kar Medical College involved in this Project work.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare that there is no conflict of interest.</p></sec><sec id="s9"><title>Cite this paper</title><p>Mukherjee, R., Ray, S.S., Mondal, S. and Chatterjee, A. (2022) Salivary Active MMP-2 of Breast Cancer Patients Is Inhibited by Guava Leaves PBS Extract. American Journal of Plant Sciences, 13, 650-658. https://doi.org/10.4236/ajps.2022.135043</p></sec></body><back><ref-list><title>References</title><ref id="scirp.117456-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Cathcart, J., Pulkoski-Gross, A. and Cao, J. (2015) Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas. Genes &amp; Diseases, 2, 26-34.  
https://doi.org/10.1016/j.gendis.2014.12.002</mixed-citation></ref><ref id="scirp.117456-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Quintero-Fabián, S., Arreola, R., Becerril-Villanueva, E., Torres-Romero, J.C., Arana-Argáez, V., Lara-Riegos, J., et al. (2019) Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Frontiers in Oncology, 9, 1370.  
https://doi.org/10.3389/fonc.2019.01370</mixed-citation></ref><ref id="scirp.117456-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Xu, X., Wang, Y., Chen, Z., Sternlicht, M.D., Hidalgo, M. and Steffensen, B. (2005) Matrix Metalloproteinase-2 Contributes to Cancer Cell Migration on Collagen. Cancer Research, 65, 130-136.</mixed-citation></ref><ref id="scirp.117456-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Celentano, A., Yap, T., Paolini, R., Yiannis, C., Mirams, M., Koo, K., et al. (2021) Inhibition of Matrix Metalloproteinase-2 Modulates Malignant Behaviour of Oral Squamous Cell Carcinoma Cells. Journal of Oral Pathology &amp; Medicine, 50, 323-332.  
https://doi.org/10.1111/jop.12992</mixed-citation></ref><ref id="scirp.117456-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Webb, A.H., Gao, B.T., Goldsmith, Z.K., Irvine, A.S., Saleh, N., Lee, R.P., et al. (2017) Inhibition of MMP-2 and MMP-9 Decreases Cellular Migration, and Angiogenesis in in Vitro Models of Retinoblastoma. BMC Cancer, 17, 1-11.  
https://doi.org/10.1186/s12885-017-3418-y</mixed-citation></ref><ref id="scirp.117456-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Amar, S. and Fields, G.B. (2015) Potential Clinical Implications of Recent Matrix Metalloproteinase Inhibitor Design Strategies. Expert Review of Proteomics, 12, 445-447. https://doi.org/10.1586/14789450.2015.1069190</mixed-citation></ref><ref id="scirp.117456-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Hidalgo, M. and Rowinsky, E.K. (2000) The Rapamycin-Sensitive Signal Transduction Pathway as a Target for Cancer Therapy. Oncogene, 19, 6680-6686.  
https://doi.org/10.1038/sj.onc.1204091</mixed-citation></ref><ref id="scirp.117456-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Bhattacharyya, N., Mondal, S., Ali, M.N., Mukherjee, R., Adhikari, A. and Chatterjee, A. (2017) Activated Salivary MMP-2-A Potential Breast Cancer Marker. The Open Conference Proceedings Journal, 8, 22-32.  
https://doi.org/10.2174/2210289201708010022</mixed-citation></ref><ref id="scirp.117456-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Lok, B., Sandai, D., Baharetha, H.M., Nazari, V.M., Asif, M., Tan, C.S., et al. (2020) Anticancer Effect of Psidium guajava (Guava) Leaf Extracts against Colorectal Cancer through Inhibition of Angiogenesis. Asian Pacific Journal of Tropical Biomedicine, 10, 293. https://doi.org/10.4103/2221-1691.284944</mixed-citation></ref><ref id="scirp.117456-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Mondal, A., Mukherjee, R., Mondal, S. and Chatterjee, A. (2021) MMP-2 Inhibitory Activity of PBS Extract of Guava Leaves. American Journal of Plant Sciences, 12, 1761-1767. https://doi.org/10.4236/ajps.2021.1212122</mixed-citation></ref><ref id="scirp.117456-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Nishida, Y., Miyamori, H., Thompson, E.W., Takino, T., Endo, Y. and Sato, H. (2008) Activation of Matrix Metalloproteinase-2 (MMP-2) by Membrane Type 1 Matrix Metalloproteinase through an Artificial Receptor for proMMP-2 Generates Active MMP-2. Cancer Research, 68, 9096-9104.  
https://doi.org/10.1158/0008-5472.CAN-08-2522</mixed-citation></ref><ref id="scirp.117456-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Mondal, S., Bardhan, K., Dutta, A. and Chatterjee, A. (2018) Identification of Vertebrate MMP-2 and MMP-9 Like Molecules in the Aqueous Extract of Nasturtium (Tropaeolum majus) Flowers, Bambusa balcooa leaves and Nayantara (Catharanthus roseus) flowers. Journal of Tumor, 6, 540-544.</mixed-citation></ref><ref id="scirp.117456-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Jiang, H. and Li, H. (2021) Prognostic Values of Tumoral MMP2 and MMP9 Overexpression in Breast Cancer: A Systematic Review and Meta-Analysis. BMC Cancer, 21, 1-13. https://doi.org/10.1186/s12885-021-07860-2</mixed-citation></ref><ref id="scirp.117456-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Itoh, Y. (2015) Membrane-Type Matrix Metalloproteinases: Their Functions and Regulations. Matrix Biology, 44, 207-223.  
https://doi.org/10.1016/j.matbio.2015.03.004</mixed-citation></ref></ref-list></back></article>